[Economic profitability: current aspects of X-ray contrast diagnosis in urology].
A diversity of X-ray contrast diagnostic techniques used in urology provides a way of using different groups of X-ray contrast materials (XCMs) in accordance of the set tasks. Many years' experience in handling water-soluble triiodinated XCMs while examining the kidneys and urinary tract provides evidence for their diagnostic effectiveness and safety. The new Triombrast (OAO "Farmac", Kiev) synthesized on the basis of the Spanish substance (Justesa Imagen SA) has successfully undergone clinical trials and meets the high requirements made by the specialized urological facilities is economically profitable. The paper has been prepared, by using the reports on the results of preclinical studies of the agent and the experience of its use in the clinic of the Research Institute of Urology and City Clinical Hospital No. 47, Moscow.
Ukolov
V A
VA
Perepanova
T S
TS
Grigor'ev
A A
AA
D000283:Administration, Intravesical; D003287:Contrast Media / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis; D003974:Diatrizoate Meglumine / Q000191:economics; D006801:Humans; D015203:Reproducibility of Results; D014567:Urography / Q000191:economics* / Q000379:methods; D014570:Urologic Diseases / Q000000981:diagnostic imaging* / Q000191:economics
D003287:Contrast Media; D003974:Diatrizoate Meglumine